NCT06080620View on ClinicalTrials.gov

The Choice of Treatment Methods and Efficacy of LABC

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 8, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

August 1, 2026

Conditions
Locally Advanced Breast Cancer
Interventions
PROCEDURE

Modified radical mastectomy for breast cancer

Modified radical mastectomy for breast cancer

PROCEDURE

neoadjuvant therapy

"neoadjuvant chemotherapy（Drugs： DoxorubicinPaclitaxelAlbumin paclitaxelCyclophosphamide）, endocrine therapy（Drugs：ToremifenZoladexAromatase inhibitors）, targeted therapy（Drugs：trastuzumabPertuzumab）"

PROCEDURE

Systematic treatment

"chemotherapyDrugs： DoxorubicinPaclitaxelAlbumin paclitaxelCyclophosphamide）, endocrine therapy（Drugs：ToremifenZoladexAromatase inhibitors）, targeted therapy（Drugs：trastuzumabPertuzumab），radiotherapy（Yikeda Versa HD linear acceleratorVarian Trilogy linear accelerator）"

Trial Locations (1)

100730

RECRUITING

Ying Xu, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER